Related Experiment Video
Updated: Jul 17, 2026

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
Excitotoxic mechanisms of ischemic injury in myelinated white matter
Selva Baltan Tekkök1, ZuCheng Ye, Bruce R Ransom
1Department of Neurology, Harborview Medical Center, University of Washington School of Medicine, Seattle, Washington 98104, USA. selva@u.washington.edu
Abstract:
Axonal injury and dysfunction in white matter (WM) are caused by many neurologic diseases including ischemia. We characterized ischemic injury and the role of glutamate-mediated excitotoxicity in a purely myelinated WM tract, the mouse optic nerve (MON). For the first time, excitotoxic WM injury was directly correlated with glutamate release. Oxygen and glucose deprivation (OGD) caused duration-dependent loss of axon function in optic nerves from young adult mice. Protection of axon function required blockade of both alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and kainate receptors, or removal of extracellular Ca(2+). Blockade of N-methyl-D-aspartate receptors did not preserve axon function. Curiously, even extended periods of direct exposure to glutamate or kainate or AMPA failed to induce axon dysfunction. Brief periods of OGD, however, caused glutamate receptor agonist exposure to become toxic, suggesting that ionic disruption enabled excitotoxic injury. Glutamate release, directly measured using quantitative high-performance liquid chromatography, occurred late during a 60-mins period of OGD and was due to reversal of the glutamate transporter. Brief periods of OGD (i.e., 15 mins) did not cause glutamate release and produced minimal injury. These results suggested that toxic glutamate accumulation during OGD followed the initial ionic changes mediating early loss of excitability. The onset of glutamate release was an important threshold event for irreversible ischemic injury. Regional differences appear to exist in the specific glutamate receptors that mediate WM ischemic injury. Therapy for ischemic WM injury must be designed accordingly.
Insights
Ischemic white matter injury involves glutamate excitotoxicity. Glutamate release, occurring late during oxygen-glucose deprivation, drives irreversible axonal damage, necessitating targeted therapies.
Area of Science:
- Neuroscience
- Neurology
- White Matter Research
Background:
- Axonal injury and dysfunction in white matter (WM) are implicated in numerous neurological diseases, notably ischemia.
- Glutamate-mediated excitotoxicity is a key factor in neurological damage.
- The mouse optic nerve (MON) serves as a model for studying purely myelinated WM tracts.
Purpose of the Study:
- To characterize ischemic injury in the mouse optic nerve (MON).
- To elucidate the role of glutamate-mediated excitotoxicity in ischemic WM injury.
- To establish a direct correlation between glutamate release and excitotoxic WM injury.
Main Methods:
- Oxygen and glucose deprivation (OGD) applied to MON to assess axon function.
- Pharmacological blockade of glutamate receptors (AMPA, kainate, NMDA).
- Extracellular Ca(2+) manipulation.
- Quantitative high-performance liquid chromatography (HPLC) for direct glutamate measurement.
Main Results:
- OGD induced duration-dependent loss of axon function in MON.
- Protection of axon function required blockade of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and kainate receptors, or Ca(2+) removal.
- N-methyl-D-aspartate receptor blockade did not preserve axon function.
- Glutamate release, measured by HPLC, occurred late during OGD (60 mins) due to transporter reversal.
- Brief OGD (15 mins) caused minimal injury and no glutamate release.
- Glutamate receptor agonist exposure was toxic only after brief OGD, indicating ionic disruption enables excitotoxicity.
Conclusions:
- Toxic glutamate accumulation during ischemia follows initial ionic changes that impair excitability.
- The onset of glutamate release is a critical threshold for irreversible ischemic WM injury.
- Specific glutamate receptors mediating WM ischemic injury may vary regionally.
- Therapeutic strategies for ischemic WM injury should consider these receptor-specific and temporal dynamics.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Cellular Injury IV: Necrosis
Neurogenesis and Regeneration of Nervous Tissue
Cytotoxic Edema: Pathophysiology
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
